Euro Lifecare Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Euro Lifecare Private Limited Pharmaceutical Export Portfolio Dataset — 4 Products, $2.1M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Euro Lifecare Private Limited — Pharmaceutical Exporter Profile (2026) | 4 Products, $2.1M Trade | TransData Nexus

Euro Lifecare Private Limited

Indian Pharmaceutical Exporter · Respiratory & OTC Specialist · $2.1M Total Trade · DGFT Verified

Euro Lifecare Private Limited is an Indian pharmaceutical exporter with a total trade value of $2.1M across 4 products in 3 therapeutic categories. Based on 100 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Phenylephrine ($1.2M), Sofosbuvir ($350.0K), Velpatasvir ($350.0K).

Euro Lifecare Private Limited — Export Portfolio & Destination Treemap

Euro Lifecare Private Limited pharmaceutical export portfolio — 4 products across 3 therapeutic categories. Source: Indian Customs (DGFT).

Who is Euro Lifecare Private Limited? — Company Overview & Market Position

Euro Lifecare Private Limited, established on October 17, 2011, is a privately held pharmaceutical company headquartered in Mumbai, Maharashtra, India. The company is registered under the Corporate Identification Number (CIN) U21002MH2011PTC223174. As of the latest available data, Euro Lifecare has an authorized capital of ₹5.00 crore and a paid-up capital of ₹2.62 crore. The company is unlisted and operates in the pharmaceutical sector, focusing on the wholesale trading of finished pharmaceutical formulations.

The company's registered office is located at Off. No.509 & 510 5th Floor, B Wing, 215 Atrium Co-Operative Premises Society Ltd, Mathuradas Vasanji Road, Chakala, Andheri East, Mumbai, Maharashtra, 400093. Euro Lifecare is led by a team of directors, including Sanjeev Kumar Bhagat, Shyam Damodar Mahale, and Rajiv Kumar. The company has demonstrated significant growth, with a 94.68% increase in total revenue and a 157.18% increase in profit for the financial year ending March 31, 2023.

What Does Euro Lifecare Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Phenylephrine$1.2M

Product Portfolio — Top 4 by Export Value

Euro Lifecare Private Limited exports 4 pharmaceutical products across 3 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Phenylephrine	Respiratory & OTC	$1.2M	66	1.5%	11
2	Sofosbuvir	Antiviral & HIV Medications	$350.0K	7	0.9%	3
3	Velpatasvir	Antiviral & HIV Medications	$350.0K	7	1.4%	3
4	Ranitidine	Gastrointestinal	$191.5K	20	1.5%	13

Euro Lifecare Private Limited exports 4 pharmaceutical products across 3 therapeutic categories with a total export value of $2.1M. The top category is Respiratory & OTC (58.2% of portfolio), followed by Antiviral & HIV Medications (32.8%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Euro Lifecare Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Specific details regarding Euro Lifecare's manufacturing facilities, including their locations, capacities, and specializations, are not publicly disclosed. The company primarily focuses on the wholesale trading of finished pharmaceutical formulations, suggesting that its manufacturing operations may be outsourced to third-party contract manufacturers. This approach is common in the pharmaceutical industry, allowing companies to leverage specialized manufacturing capabilities without the need for in-house facilities.

3Key Leadership

Euro Lifecare Private Limited is managed by a team of directors:

Sanjeev Kumar Bhagat: Director since October 17, 2011.
Shyam Damodar Mahale: Director since March 13, 2014.
Rajiv Kumar: Whole-Time Director since October 30, 2013.

These leaders are responsible for overseeing the company's strategic direction and operations. Their combined experience contributes to Euro Lifecare's growth and success in the pharmaceutical sector.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Euro Lifecare Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Euro Lifecare Private Limited's export activities, as reported by TransData Nexus, include a total export value of $2.1 million USD across 100 shipments, with products spanning three therapeutic categories. The company's top five exported products are:

Phenylephrine: $1.2 million USD, ranking #11 with a 1.5% market share.
Sofosbuvir: $350,000 USD, ranking #3 with a 0.9% market share.
Velpatasvir: $350,000 USD, ranking #3 with a 1.4% market share.
Ranitidine: $191,000 USD, ranking #13 with a 1.5% market share.

The primary therapeutic categories for these exports are:

Respiratory & OTC: 58.2%
Antiviral & HIV Medications: 32.8%
Gastrointestinal: 9.0%

While specific regulatory approvals in the United States, European Union, United Kingdom, Australia, and Japan are not detailed in the available data, the company's export activities suggest compliance with international standards. The presence of products like Sofosbuvir and Velpatasvir, which are used in the treatment of hepatitis C, indicates adherence to stringent regulatory requirements. For instance, Sofosbuvir has been approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), reflecting the company's capability to meet the regulatory standards of these markets.

Euro Lifecare Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Euro Lifecare's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. The company's export of products like Sofosbuvir and Velpatasvir, which are approved by the FDA, suggests that Euro Lifecare may have engaged in the necessary regulatory processes to facilitate these exports. However, without explicit confirmation of FDA approvals or registrations, it is challenging to provide a comprehensive assessment of the company's standing with the FDA.

2WHO & EU GMP

The available data does not specify whether Euro Lifecare holds World Health Organization (WHO) prequalification or European Union Good Manufacturing Practice (EU GMP) certificates. Given the company's export activities, including products like Sofosbuvir and Velpatasvir, it is plausible that Euro Lifecare adheres to international quality standards. However, without explicit confirmation of WHO prequalification or EU GMP certification, a definitive assessment cannot be made.

3CDSCO & Indian Regulatory

Euro Lifecare Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Euro Lifecare operates in a competitive pharmaceutical export market, with numerous companies offering similar products across therapeutic categories. The company's focus on a select range of products, as indicated by its export data, may provide a niche advantage in specific markets. However, the lack of diversification could also expose the company to competitive pressures in these areas. A detailed market share comparison and head-to-head analysis would require access to proprietary market research data.

2Key Differentiators

Euro Lifecare's strategic focus on a select range of products allows for specialized marketing efforts and operational efficiencies. The inclusion of antiviral medications like Sofosbuvir and Velpatasvir in its export portfolio indicates a commitment to addressing critical healthcare needs. However, the concentration of the product portfolio may limit the company's ability to leverage opportunities in other therapeutic areas.

3Strategic Position

Euro Lifecare's current strategic direction appears to be centered on the export of a select range of pharmaceutical products, particularly in the antiviral and respiratory categories. This focus may enable the company to establish a strong presence in specific markets. Looking ahead, diversifying the product portfolio and exploring new therapeutic areas could enhance the company's resilience and growth prospects.

Buyer Due Diligence Brief — Evaluating Euro Lifecare Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Euro Lifecare's export data indicates a consistent volume of shipments, suggesting reliable supplier relationships. The company's focus on a select range of products may contribute to operational consistency and quality control. However, the concentration of the product portfolio could pose risks if market dynamics shift or if there are disruptions in the supply chain for these specific products.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Approval: Confirm that the products are approved by the U.S. Food and Drug Administration. Verification can be done through the FDA's official

TransData Nexus Research · FDA, WHO, EMA regulatory databasesMar 2026

Frequently Asked Questions — Euro Lifecare Private Limited

How many pharmaceutical products does Euro Lifecare Private Limited export from India?

Euro Lifecare Private Limited exports 4 pharmaceutical products across 3 therapeutic categories. The top exports are Phenylephrine ($1.2M), Sofosbuvir ($350.0K), Velpatasvir ($350.0K), Ranitidine ($191.5K). Total export value is $2.1M.

What is Euro Lifecare Private Limited's total pharmaceutical export value?

Euro Lifecare Private Limited's total pharmaceutical export value is $2.1M, based on 100 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Euro Lifecare Private Limited cover?

Euro Lifecare Private Limited exports across 3 therapeutic categories. The largest are Respiratory & OTC (58.2%, 1 products), Antiviral & HIV Medications (32.8%, 2 products), Gastrointestinal (9.0%, 1 products).

Get Full Euro Lifecare Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.